Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.

Adachi K, Ghory PK, Asakura T, Schwartz E.

Proc Natl Acad Sci U S A. 1977 Feb;74(2):501-4.

2.

Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.

Wang C, Chiarelli LR, Bianchi P, Abraham DJ, Galizzi A, Mattevi A, Zanella A, Valentini G.

Blood. 2001 Nov 15;98(10):3113-20.

3.

Pyruvate kinase of Streptococcus lactis.

Collins LB, Thomas TD.

J Bacteriol. 1974 Oct;120(1):52-8.

4.

An isozyme of erythrocyte pyruvate kinase (PK-Los Angeles) with impaired kinetics corrected by fructose-1, 6-diphosphate.

Paglia DE, Valentine WN, Williams KO, Konrad PN.

Am J Clin Pathol. 1977 Aug;68(2):229-34.

PMID:
18004
5.

[Studies on erythrocyte pyruvate kinase. I. Some properties of the normal human enzyme].

Boivin P, Galand C, Demartial MC.

Pathol Biol (Paris). 1972 Jun-Jul;20(11):583-94. French. No abstract available.

PMID:
4558576
6.

Effects of calcium ions on pyruvate kinase from human erythrocytes.

Flikweert JP, Hoorn RK, Staal GE.

Biochimie. 1975;57(6-7):677-81.

PMID:
1203317
7.

Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.

Lakomek M, Winkler H, Pekrun A, Krüger N, Sander M, Huppke P, Schröter W.

Enzyme Protein. 1994-1995;48(3):149-63.

PMID:
8589802
8.

Studies with human erythrocyte pyruvate kinase (PK): effects of modification of sulfhydryl groups.

Valentine WN, Paglia DE.

Br J Haematol. 1983 Mar;53(3):385-98.

PMID:
6824584
9.

Pyruvate kinase deficiency: characterization of two new genetic variants.

Dente L, D'Urso M, Di Maio S, Brancaccio V, Luzzatto L.

Clin Chim Acta. 1982 Dec 9;126(2):143-54.

PMID:
7151276
10.
11.

[Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].

Boivin P, Galand C.

Pathol Biol (Paris). 1977 Mar;25(3):161-7. French.

PMID:
323784
12.

Pyruvate kinase Greensboro. A four-generation study of a high K0.5s (phosphoenolpyruvate) variant.

Valentine WN, Herring WB, Paglia DE, Steuterman MC, Brockway RA, Nakatani M.

Blood. 1988 Sep;72(3):1054-9. Erratum in: Blood 1988 Dec;72(6):2082.

13.

Purification and kinetic properties of pyruvate kinase from Brochothrix thermosphacta.

Singh SP, Rogers PJ.

Biochem Int. 1991 Sep;25(1):35-45.

PMID:
1772447
14.

The molecular heterogeneity of red cell enzymopathies.

Löhr GW, Blume KG, Arnold H.

Isr J Med Sci. 1973 Sep-Oct;9(9):1361-4. No abstract available.

PMID:
4775119
15.

A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate.

Boivin P, Galand C.

Enzyme. 1974;18(1):37-47. No abstract available.

PMID:
4850232
16.
18.

On the molecular basis of pyruvate kinase deficiency.

Blume KG, Arnold H, Löhr GW, Scholz G.

Biochim Biophys Acta. 1974 Dec 29;370(2):601-4. No abstract available.

PMID:
4378430
19.

The regulatory properties of yeast pyruvate kinase. Effect of pH.

Kinderlerer J, Ainsworth S, Morris CN, Rhodes N.

Biochem J. 1986 Mar 15;234(3):699-703.

20.

Stabilization of different conformational states of liver pyruvate kinase type L by the allosteric activators.

Rozengurt E, Jimenez de Asua L, Carminatti H.

FEBS Lett. 1973 Dec 1;37(2):225-7. No abstract available.

Supplemental Content

Support Center